Immunohistochemiczna lokalizacja telomerazy w chloniakach zlosliwych u psow

• Autorzy: Dzimira S , Madej J.A. , Nowak M.
• Języki publikacji: PL

Abstrakty

EN

Telomerase is a ribonucleoprotein enzyme responsible for the protection of telomeres - structures which play a key role in stabilizing chromosomes. Its presence assures the possibility of tissue regeneration and unlimited cell division. On the physiological level telomerase activity is present in germline cells, embryonic tissues and some hematopoetic stem cells and, on a pathological level, in neoplastic cells. Its expression causes uncontrolled cell proliferation and may be a characteristic marker of neoplastic transformation and tumor progression. The aim of the study was to present the presence of telomerase in neoplastic lymphocytes in cases of lymphoma malignum in dogs. Cytoimmunological procedure with Telomerase (catalytic unit) NCL-L-hTERT (Novocastra Ltd product) was used to locate telomerase in malignantly transformed lymphocytes and in normal lymphocytes. The study indicated that telomerase is not present in normal lymphocytes. Higher levels of telomerase were observed in cenroblastic and immunoblastic lymphoma cells, compared with lower amounts of the enzyme in lymphoma malignum lymphocyticum B cells. A distinct presence of the enzyme was also noted in lymphoma cells of skin T-receptors. The level of this ribonucleoprotein may serve as a malignancy marker of transformed lymphocytes.

Słowa kluczowe

PL

chloniaki; nowotwory; psy; telomeraza; komorki nowotworowe; chloniak zlosliwy; choroby zwierzat

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 02
• Opis fizyczny: s.215-218,fot.,bibliogr.

Twórcy

autor

Dzimira S

• Akademia Rolnicza, ul. Norwida 31, 50-375 Wroclaw

autor

Madej J.A.

autor

Nowak M.

Bibliografia

• 1.Aogi K., Kitahara K., Buley I., Backdahl M., Tahara H., Sugino T., Tarin D., Goodison S.: Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. Clin. Cancer. Res. 1998, 4, 1956-1970.
• 2.Argyle D. J., Nasir L.: Telomerase: A potential diagnostic and therapeutic toll in canine oncology. Vet. Pathol. 2003, 40, 1-7.
• 3.Biller B. J., Kitchell B. E., Cadile C. D.: Evaluation of an assay detecting telomerase activity in neoplastic tissues of dogs. Am. J. vet. Res. 1998, 59, 1526-1529.
• 4.Blackburn E. H.: Telomere states and cell fates. Nature 2000, 408, 53-56.
• 5.Cadile C. D., Kitchell B. E., Biller., Hetler E. R., Balkin R. G.: Telomerase activity as a marker for malignancy in feline tissues. Am. J. vet. Res. 2001, 62, 1578-1581.
• 6.Carioto L. M., Kruth S. A., Betts D. H., King W. A.: Telomerase activity in clinically normal dogs and dogs with malignant lymphoma. Am. J. vet. Res. 2001, 62, 1142-1146.
• 7.Funakoshi Y., Nakayama H., Uetsuka K., Nishimura R., Sasaki N., Doi K.: Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet. Pathol. 2000, 37, 177-183.
• 8.Klapper W., Krams M., Qian W., Janssen D., Parwaresch R.: Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br. J. Cancer 2003, 89, 713-719.
• 9.Lechowski R., Żmudzka M.: Telomeraza główne kierunki badañ. Medycyna Wet. 2003, 59, 100-103.
• 10.MacNamara B., Wang W., Chen Z., Hou M., Mazur J., Gruber A., Porwit- -MacDonald A.: Telomerase activity in relation to pro- and anti-apoptic protein expression in high grade non-Hodgkin's lymphomas. Haematologica 2001, 86, 386-393.
• 11.Nasir L., Devlin P., Mckevitt T., Rutteman G., Argyle D. J.: Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology. Neoplasia 2001, 3, 351-359.
• 12.Nasir L., Gault E., Campbell S., Veeramalai M., Gilbert D., McFarlane R., Munro A., Argyle D. J.: Isolation and expression of the reverse transcriptase component of Canis familiaris telomerase ribonucleoprotein (dog TERT). Gene 2004, 336, 105-113.
• 13.Norrback F., Hultdin M., Dahlenborg K., Osterman P., Carlsson R., Roos G.: Telomerase regulation and telomere dynamics in germinal centers. Eur. J. Haematol. 2001, 67, 309-317.
• 14.Nowis D., Gołąb J.: Rola telomerów i telomerazy w progresji nowotworów. Perspektywy diagnostyczne i terapeutyczne. Post. Biol. Kom. 2002, 29, 243- -262.
• 15.Poole J. C., Andrews L. G., Tollefsbol T. O.: Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 2001, 269, 1-12.
• 16.Rahman R., Latonen L., Wiman K. G.: hTERT antagonizes p53-induced apoptosis independently of telomeraze activity. Oncogene 2005, 8, 1320-1327.
• 17.Wang Z., Ramin S. A., Tsai C., Lui P., Ruckle H. C., Beltz R. E., Sands J. F., Slattery C. W.: Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens. Urol. Oncol. 2002, 7, 199-205.
• 18.Wu K., Lund M., Bang K., Thestrup-Pedersen K.: Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer 1999, 86, 1056-1063.
• 19.Yashima K., Piatyszek M. A., Saboorian H. M., Virmani A. K., Brown., Shay J. W., Gazdar A. F.: Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J. Clin. Pathol. 1997, 50, 110-117.
• 20.Yazawa M., Okuda M., Setoguchi A., Iwabuchi S., Nashimura R., Sasaki N., Masuda K., Ohno K., Ttsujimoto H.: Telomere length and telomerase activity in canine mammary gland tumors. Am. J. vet. Res., 2001, 62, 1539-1543.
• 21.Żmudzka M., Malicka E., Sobczak-Filipiak M., Lechowski R.: Telomerase activity in squamous cell carcinoma in dogs. Pol. J. Vet. Sci. 2004, 7, Supplement, 171-172